08:59 AM EDT, 08/12/2024 (MT Newswires) -- MIRA Pharmaceuticals ( MIRA ) on Monday filed a registration statement for the potential sale of up to $100 million of its securities from time to time.

The filing covers common and preferred stock, warrants and units.

The company said it will use the net proceeds for general corporate purposes, unless it specifies another use in the applicable prospectus supplement.

Price: 2.1700, Change: +0.07, Percent Change: +3.33